Aldeyra logo

Aldeyra

ALDX | NASDAQ
Chart Builder DCF Calculator
$0.68
+$0.04 (+5.62%)
At close: Nov 16, 2026, 3:59 PM ET
$0.67
-$0.01 (-1.53%)
After-hours: Nov 16, 2026, 7:30 PM ET
+5.62%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
36.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #626/1021 (Top 61%)

Key Statistics

Market Data

Market Cap $40.99M
1D Range
0.65 0.69
52W Range
0.56 5.62

Valuation (TTM)

PE -2.12
PB 0.00
EV/EBITDA N/A

Valuation (NTM)

Forward PE 5.18
Forward PEG 0.06
Price Target $10.00
Loading financial charts...

Profile

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species ...

Sector Healthcare
Industry Biotechnology
Employees 6
IPO Date May 2, 2014
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Hold
Price Target
$10.00
Upside
+1370.59%
Buy (1)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.